The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...

Model Lottie Moss is speaking out against the use of diabetes medication for weight loss after she allegedly overdosed on ...

It is believed that Rybelsus is great for Weight Loss Here are some effective economic and safe OTC Rybelsus Alternative ...

A new study shows that a slow-release form of semaglutide could enable people using Wegovy or Ozempic to switch from weekly to once-a-month injections. The new formulation encases semaglutide in a ...

Shares in Novo Nordisk rose by about 2% on Wednesday, driven by positive data from its new obesity drug, amycretin, which ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

Researchers in France have developed a once-a-month hydrogel-based delivery system for semaglutide, significantly simplifying ...